16
total announcements
STALLION.NS · 15 min delayed
Stallion India Fluorochemicals Limited
Stallion India Fluorochemicals Limited has informed the Exchange about the schedule of an Analyst/Investor Meeting on September 8, 2026, at the company's registered office. The meeting will be held virtually with Canara HSBC Life Insurance. No unpublished price sensitive information (UPSI) will be discussed.
Stallion India Fluorochemicals Limited
Stallion India Fluorochemicals Limited has informed the Exchange about the completion of dispatch of the AGM notice and e-voting information for the 24th Annual General Meeting through newspaper advertisements, as per Section 108 of the Companies Act, 2013, and Regulations 44 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Stallion India Fluorochemicals Limited
Stallion India Fluorochemicals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 21, 2026.
Stallion India Fluorochemicals Limited
Stallion India Fluorochemicals Limited
Stallion India Fluorochemicals Limited has informed the Exchange about the transcript of the Investor Conference held on Monday, 17th August, 2026, at 04.00 P.M. IST with regard to the business and financial performance of the Company for the quarter ended 30th June, 2026. The transcript has also been uploaded on the Company’s website.
Stallion India Fluorochemicals Limited
Stallion India Fluorochemicals Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, regarding the utilization of proceeds from its Rights Issue. The report indicates no deviation from the objects of the issue, and the Monitoring Agency has declared that the report provides an objective view of the utilization of the issue proceeds.
Stallion India Fluorochemicals Limited
Stallion India Fluorochemicals Limited has made available the audio recording of its earnings conference call held on August 17, 2026, to discuss its unaudited financial results for the quarter ended June 30, 2026.
Stallion India Fluorochemicals Limited
Stallion India Fluorochemicals Limited has informed the Exchange about Investor Presentation for the Quarter ended 30th June, 2026, to be made to the investors and analysts.
Stallion India Fluorochemicals Limited
Stallion India Fluorochemicals Limited has announced its unaudited financial results for Q1 FY26-27, reporting a 12.78% YoY increase in total revenue to ₹124.68 crore, a 75.85% YoY increase in EBITDA to ₹25.27 crore, and a 79.15% YoY increase in PAT to ₹18.57 crore.
Stallion India Fluorochemicals Limited
Stallion India Fluorochemicals Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, detailing the utilization of proceeds from its Initial Public Offer (IPO). The report states that there were minor deviations from the objects specified in the offer document, but these have been revised and approved by the shareholders. The company has utilized the proceeds for the purchase of land for a warehouse, which was initially specified for construction, and has also made excess utilization of funds towards issue expenses.
Stallion India Fluorochemicals Limited
Stallion India Fluorochemicals Limited has published its unaudited financial results for the quarter ended 30th June, 2026, showing a total income from operations of ₹6.56 crores and a net profit of ₹0.46 crores.
Stallion India Fluorochemicals Limited
Stallion India Fluorochemicals Limited has informed the Exchange about a conference call scheduled for August 17, 2026, to discuss Q1 FY 2026-27 financial results.
Stallion India Fluorochemicals Limited
Stallion India Fluorochemicals Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, along with a limited review report from the statutory auditors. The board of directors has approved the financial results, management discussion and analysis report, and corporate governance report for the financial year ended March 31, 2026. The company has also scheduled its annual general meeting for September 21, 2026.
Stallion India Fluorochemicals Limited
Stallion India Fluorochemicals Limited has informed the Exchange about the schedule of an Analyst/Investor Meeting on July 21, 2026, with various analysts and investors, and has assured that no unpublished price sensitive information will be discussed.
Stallion India Fluorochemicals Limited
Stallion India Fluorochemicals Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June, 2026, confirming that no members of the company requested rematerialisation during this period.
Stallion India Fluorochemicals Limited
Stallion India Fluorochemicals Limited has closed its trading window for insiders due to the declaration of unaudited financial results for the quarter ended June 30, 2026.